Privium Fund Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Buy |
46,000
+11,500
| +33% | +$327K | 0.28% | 27 |
|
|
2025
Q1 | $1.02M | Buy |
34,500
+2,600
| +8% | +$76.8K | 0.27% | 32 |
|
|
2024
Q4 | $928K | Buy |
31,900
+6,300
| +25% | +$183K | 0.21% | 34 |
|
|
2024
Q3 | $1.18M | Buy |
25,600
+3,358
| +15% | +$154K | 0.29% | 32 |
|
|
2024
Q2 | $863K | Buy |
22,242
+14,200
| +177% | +$551K | 0.22% | 47 |
|
|
2024
Q1 | $205K | Buy |
+8,042
| New | +$205K | 0.05% | 83 |
|